期刊文献+

心房肌基质金属蛋白酶-2和组织金属蛋白酶抑制因子-2的表达改变对风湿性心脏病二尖瓣狭窄合并房颤患者心房结构重构机制的研究 被引量:2

A research on the effects of matrix metalloproteinase-2 and tissue inhibitor-2 of metalloproteinase expression on atrial structural remodeling in patients with atrial fibrillation caused by rheumatic heart disease
下载PDF
导出
摘要 目的探讨基质金属蛋白酶-2(MMP-2)和组织金属蛋白酶抑制因子-2(TIMP-2)的基因表达水平变化与风湿性心脏病二尖瓣狭窄合并房颤患者心房结构重构的相关关系。方法选取进行二尖瓣置换术的风湿性心脏病二尖瓣狭窄合并房颤患者42例为房颤组;风湿性心瓣膜病窦性心律l8例为对照组。上述患者术前均行经胸超声心动图检查及留取相关临床资料。于手术时取左心耳心肌标本,采用Masson三色染色法检测心房肌组织纤维化程度;RT-PCR方法检测心房肌组织MMP-2和TIMP-2的mRNA水平。结果(1)房颤组患者心房肌组织纤维化比例较对照组显著升高(P<0.01),心肌组织纤维化程度与左房内径(r=0.788,P<0.001)呈显著正相关,与二尖瓣口面积(r=-0.886,P<0.05)呈负相关;(2)与对照组比较,房颤组患者心房肌组织MMP-2mRNA表达量增高(P<0.05);TIMP-2mRNA表达量降低(P<0.05)。(3)MMP-2和TIMP-2mRNA表达水平之间呈显著负相关(rp=-0.766,P<0.001)。MMP-2mR-NA表达水平与左心耳心肌组织纤维化程度(rp=0.919,P<0.001)呈显著正相关;TIMP-2mRNA表达水平与左心耳心肌组织纤维化程度(rp=-0.883,P<0.001)呈显著负相关。结论心房组织MMP-2和TIMP-2的基因表达改变,尤其是MMP-2/TIMP-2表达的失衡,是风湿性心脏病二尖瓣狭窄时心房扩大及房颤发生与维持的重要机制之一。 Objective To investigate the matrix metalloproteinase-2 (MMP-2) and tissue inhibitor-2 of metalloproteinase (TIMP-2) mRNA expression in patients with atrial fibrillation caused by rheumatic heart disease and to evaluate the influence of MMP-2 and TIMP-2 expression on the progress of atrial structural remodeling. Methods 42 patients with chronic atrial fibrillation(AF) caused by mitral valve straitness of rheumatic heart disease were as experimental group, and 18 patients with sinus rhythm were as control group. Before operation, all of the above patients underwent transthoracic echocardiograph, and related clinical date were collected. Left atrial appendage (LAA) tissue samples were obtained from these patients during mitral valve replacement operation. Collagen fibers in left atrial appendage were observed by Masson trichrome stain. MMP-2 and TIMP-2 mRNA expressions were determined by reverse transcription polymerase chain reaction (RT-PCR). Results ( 1 ) Compare with control group,the content of collagen fibers in LAA increased significantly in patients with AF( P 〈0.01 ). The content of collagen fibers in LAA was significantly correlated with left atrial dimension( r = 0. 788, P 〈 0.001 ) and the aera of mitral valve ( r = - 0. 886, P 〈 0.05 ). (2) Compared with control group,the expressions of MMP-2 mRNA( P 〈 0.05 ) in the LAA tissue of the AF group was up-regulated significantly;the expressions of TIMP-2 mRNA (P 〈 0.05 ) in the LAA tissue of the AF group was down-regulated significantly. (3)The expressions of M MP-2 mRNA was signifi- cantly correlated with TIMP-2 mRNA ( rp = - 0. 766, P 〈 0. 001 ). The MMP-2 was significantly correlated with the content of collagen fibers in LAA( r, =0. 869 ,P 〈 0. 001 ). The TIMP-2 was significantly correlated with the content of collagen fibem in LAA ( rp = - 0. 830, P 〈 0. 001 ).Conclusion The selective down-regulation of TIMP-2 and up-regulation of MMP-2 gene expression in atrium,especially the unbalanced change of the MMP-2 and TIMP-2 gene expression ,could be one of the molecular mechanisms of atrial structural remodeling in patients with atrial fibrillation caused by rheumatic heart disease ,which correlates with the initiation and maintenance of AF.
出处 《内科》 2008年第3期332-335,共4页 Internal Medicine
基金 广西科学基金项目资助(桂科攻0816004-24)
关键词 风湿性心脏病 心房颤动 基质金属蛋白酶 金属蛋白酶类组织抑制剂 Rheumatic Heart Disease Atrial fibrillation Matrix metalloproteinase Tissue inhibitor of metalloproteinase
  • 相关文献

参考文献3

二级参考文献52

  • 1Coussens LM, Fingleton B, Matrlsian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations [ J]. Science, 2002, 295(5564) :2387-2392.
  • 2Bodh I. Ventricular remodeling after infarction and the extracellular collagen matrix:When is enough enough? [ J 1. Circulation,2003,108 ( 11 ) :1395-1403.
  • 3Jugdutt BI. Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways [J]. Curt Drug Targets Cardiovasc Haematol Disord,2003,3:1-30.
  • 4Wilson EM. Moainie SL, Baskin JM. Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling[J].Circulation ,2003,107 (22) :2857-2863.
  • 5Lindsey ML, Mann DL, Entman ML, et al. Extracellular matrix remodeling following myocardial injury[J]. Ann Med,2003,35(5) :316-326.
  • 6Creemers EE. Cieutjens JP, Smits JF. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?[J]. Circ Res,2001,89(3) :201-210.
  • 7Visse R,Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases :structure. function, and biochemistry [ J]. Circ Res ,2003,92(8) :827-839.
  • 8Deten A, Holzl A, Leicht M. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats[ J]. J Mol Cell Cardiol,2001,33 (6) : 1191-207.
  • 9Peterson JT, Li H, Dillon L, et al. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat[ J]. Cardiovasc Res ,2000,46(2) :307-315.
  • 10Fedak PW, Altamentova SM, Weisel RD,et al. Matrix remodeling in experimental and human heart failure:a possible regulatory role for TIMP-3[J]. Am J Physiol,2003 ,284 :626-634.

共引文献28

同被引文献18

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部